MedPath

Clinical study on the effects of vildagliptin on glucose and lipid profiles in patients type 2 diabetes mellitus

Not Applicable
Conditions
type 2 diabetes mellitus
Registration Number
JPRN-UMIN000010451
Lead Sponsor
Department of Cardiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1)patients with hypersensitivity to targeted medication 2)type 1 diabetes, diabetic ketoacidosis or diabetic coma 3)patients with severe liver dysfunaction 4)patients with severe infection or traumatic injury 5)pregnat, female with possiboility of pregnancy and breast-feeding 6)patients with severe complications 7)any other factors that may disqualify patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath